carbendazim
Term · Oncology and biomedicine · MLC-T-ONC-001407
An anticancer drug that belongs to the family of drugs called antifungal agents.
A broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities. Although the exact mechanism of action is unclear, carbendazim appears to binds to an unspecified site on tubulin and suppresses microtubule assembly dynamic. This results in cell cycle arrest at the G2/M phase and an induction of apoptosis.
| Identifier | MLC-T-ONC-001407 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | BCM |
| Synonyms | carbendazole |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001407",
"term": "carbendazim",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that belongs to the family of drugs called antifungal agents.",
"A broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities. Although the exact mechanism of action is unclear, carbendazim appears to binds to an unspecified site on tubulin and suppresses microtubule assembly dynamic. This results in cell cycle arrest at the G2/M phase and an induction of apoptosis."
],
"abbreviation": "BCM",
"synonyms": [
"carbendazole"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/carbendazim/"
}
Record 4,136 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.